Pregnancy poses no greater risk to breast cancer survivors

besa

https://medicalxpress.com/news/2017-10-pregnancy-p...

https://www.sciencedaily.com/releases/2017/10/1710...

"These findings show that pregnancy does not increase the risk of breast cancer recurrence, alleviating fears that pregnancy poses a greater risk to breast cancer survivors"

Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status

Matteo Lambertini Niels Kroman Lieveke Ameye Octavi Cordoba Alvaro Pinto Giovanni Benedetti Maj-Britt Jensen Shari Gelber Maria Del Grande Michail Ignatiadis ... Show more JNCI: Journal of the National Cancer Institute, djx206, https://doi.org/10.1093/jnci/djx206 Published:

https://academic.oup.com/jnci/article-abstract/doi...

Below is abstract of original journal article from the Journal of the National Cancer Institute,

"26 October 2017

Abstract

Safety of pregnancy in women with history of estrogen receptor (ER)–positive breast cancer remains controversial. In this multicenter case–control study, 333 patients with pregnancy after breast cancer were matched (1:3) to 874 nonpregnant patients of similar characteristics, adjusting for guaranteed time bias. Survival estimates were calculated using the Kaplan-Meier analysis; groups were compared with the log-rank test. All reported P values were two-sided. At a median follow-up of 7.2 years after pregnancy, no difference in disease-free survival was observed between pregnant and nonpregnant patients with ER-positive (hazard ratio [HR] = 0.94, 95% confidence interval [CI] = 0.70 to 1.26, P = .68) or ER-negative (HR = 0.75, 95% CI = 0.53 to 1.06, P = .10) disease. No overall survival (OS) difference was observed in ER-positive patients (HR = 0.84, 95% CI = 0.60 to 1.18, P = .32); ER-negative patients in the pregnant cohort had better OS (HR = 0.57, 95% CI = 0.36 to 0.90, P = .01). Abortion, time to pregnancy, breastfeeding, and type of adjuvant therapy had no impact on patients' outcomes. This study provides reassuring evidence on the long-term safety of pregnancy in breast cancer survivors, including those with ER-positive disease."